1
|
Smith M and Visootsak J: Noninvasive
screening tools for Down syndrome: A review. Int J Womens Health.
5:125–131. 2013.PubMed/NCBI
|
2
|
Avent ND: Maternal plasma biomarkers for
down syndrome: Present and future. Drugs Today (Barc). 49:145–152.
2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Alldred SK, Deeks JJ, Guo B, Neilson JP
and Alfirevic Z: Second trimester serum tests for Down's Syndrome
screening. Cochrane Database Syst Rev. 13:CD0099252012.
|
4
|
Androutsopoulos G, Gkogkos P and Decavalas
G: Mid-trimester maternal serum HCG and alpha fetal protein levels:
Clinical significance and prediction of adverse pregnancy outcome.
Int J Endocrinol Metab. 11:102–106. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Extermann P, Bischof P, Marguerat P and
Mermillod B: Second-trimester maternal serum screening for Down's
syndrome: Free beta-human chorionic gonadotrophin (HCG) and
alpha-fetoprotein, with or without unconjugated oestriol, compared
with total HCG, alpha-fetoprotein and unconjugated oestriol. Hum
Reprod. 13:220–223. 1998. View Article : Google Scholar : PubMed/NCBI
|
6
|
Shaw SW, Hsu JJ, Lee CN, Hsiao CH, Chen
CP, Hsieh TT and Cheng PJ: First- and second-trimester Down
syndrome screening: Current strategies and clinical guidelines.
Taiwan J Obstet Gynecol. 47:157–162. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sayin NC, Canda MT, Ahmet N, Arda S, Süt N
and Varol FG: The association of triple-marker test results with
adverse pregnancy outcomes in low-risk pregnancies with healthy
newborns. Arch Gynecol Obstet. 277:47–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wang YY, Luo J, Zhu MW, Liu LN and Ma X:
Second-trimester double or triple screening for Down syndrome: A
comparison of Chinese and Caucasian populations. Int J Gynaecol
Obstet. 94:67–72. 2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Sifakis S, Papantoniou N, Kappou D and
Antsaklis A: Noninvasive prenatal diagnosis of Down syndrome:
Current knowledge and novel insights. J Perinat Med. 40:319–327.
2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Nicolaides KH, Syngelaki A, Gil M,
Atanasova V and Markova D: Validation of targeted sequencing of
single-nucleotide polymorphisms for non-invasive prenatal detection
of aneuploidy of chromosomes 13, 18, 21, X and Y. Prenat Diagn.
33:575–579. 2013. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Shaw SW, Chen CP and Cheng PJ: From Down
syndrome screening to noninvasive prenatal testing: 20 years'
experience in Taiwan. Taiwan J Obstet Gynecol. 52:470–474. 2013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Ehrich M, Deciu C, Zwiefelhofer T, Tynan
JA, Cagasan L, Tim R, Lu V, McCullough R, McCarthy E, Nygren AO, et
al: Noninvasive detection of fetal trisomy 21 by sequencing of DNA
in maternal blood: A study in a clinical setting. Am J Obstet
Gynecol. 204:205.e1–11. 2011. View Article : Google Scholar
|
13
|
Baffero GM, Somigliana E, Crovetto F,
Paffoni A, Persico N, Guerneri S, Lalatta F, Fogliani R and Fedele
L: Confined placental mosaicism at chorionic villous sampling: Risk
factors and pregnancy outcome. Prenat Diagn. 32:1102–1108. 2012.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Bamberg C, Fotopoulou C, Thiem D, Roehr
CC, Dudenhausen JW and Kalache KD: Correlation of midtrimester
amniotic fluid cytokine concentrations with adverse pregnancy
outcome in terms of spontaneous abortion, preterm birth and
preeclampsia. J Matern Fetal Neonatal Med. 25:812–817. 2012.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Guedj F and Bianchi DW: Noninvasive
prenatal testing creates an opportunity for antenatal treatment of
Down syndrome. Prenat Diagn. 33:614–618. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Van Opstal D and Srebniak MI: Cytogenetic
confirmation of a positive NIPT result: Evidence-based choice
between chorionic villus sampling and amniocentesis depending on
chromosome aberration. Expert Rev Mol Diagn. 16:513–520. 2016.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Yu DY, Fu P, Zhang ZH, Wang F, Han MY, Ren
HY, Zhao W, Zhang K, Li S and Jiang N: Evaluation of Down's
syndrome screening methods using maternal serum biochemistry in the
second trimester pregnancy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
28:332–335. 2011.(In Chinese). PubMed/NCBI
|
18
|
Lim JH, Park SY and Ryu HM: Non-invasive
prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in
maternal blood. Obstet Gynecol Sci. 56:58–66. 2013. View Article : Google Scholar : PubMed/NCBI
|